Hospital-acquired C. diff comes with a financial price tag

The average healthcare cost for patients with the C. diff infection was $43,718


A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.

In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.

The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.

The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.

Read the article.



August 5, 2019


Topic Area: Infection Control


Recent Posts

On the Lookout: The Software Supply Chain as a Healthcare Cyberattack Vector

Staying watchful of third-party software vendors and their activities is critical for healthcare cybersecurity.


Hackensack Meridian Health & Wellness Center at Clifton Opens

The Clifton center expands health care access in Passaic County by reducing barriers such as travel and wait times.


Suffolk Breaks Ground on Expansion of White Plains Hospital

The 10-story, approximately 500,000-square-foot expansion is slated to open in 2028.


EVS Leadership Culture Critical in Preventing Hospital-Acquired Sepsis

Cleaning is an essential yet complex component for the prevention of HAI-induced sepsis.


Man Dies by Suicide in Emergency Department Waiting Room at Kansas Hospital

No staff or patients were harmed, and the man was alone in the waiting area when he shot himself.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.